Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06993168
PHASE1
To Evaluate Effect of Food of DA-5222 in Healthy Adult Subjects
Sponsor: Dong-A ST Co., Ltd.
View on ClinicalTrials.gov
Summary
This study is to evaluate the effect of food on pharmacokinetics of DA-5222 in healthy adult subjects
Official title: An Open-label, Randomized, Single-dose, 2-sequence, 2-period, Crossover Phase 1 Study to Evaluate the Effect of Food on the Pharmacokinetic Characteristics of DA-5222 in Healthy Adult Subjects
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
32
Start Date
2025-05-21
Completion Date
2025-07
Last Updated
2025-05-28
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
DA-5222
single dose administration (DA-5222 one tablet once a day)
Locations (1)
Bumin Hospital
Seoul, South Korea, South Korea